272 related articles for article (PubMed ID: 25928412)
41. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia.
Wyszynski DF; Baldwin CT; Cleves MA; Amirault Y; Nolan VG; Farrell JJ; Bisbee A; Kutlar A; Farrer LA; Steinberg MH
Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):23-33. PubMed ID: 15040424
[TBL] [Abstract][Full Text] [Related]
42. Protective BCL11A and HBS1L-MYB polymorphisms in a cohort of 102 Congolese patients suffering from sickle cell anemia.
Mikobi TM; Tshilobo Lukusa P; Aloni MN; Lumaka AZ; Kaba DK; Devriendt K; Matthijs G; Mbuyi Muamba JM; Race V
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28332727
[TBL] [Abstract][Full Text] [Related]
43. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
[TBL] [Abstract][Full Text] [Related]
44. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
Menzel S; Thein SL
Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
[TBL] [Abstract][Full Text] [Related]
45. Discovering the genetics underlying foetal haemoglobin production in adults.
Thein SL; Menzel S
Br J Haematol; 2009 May; 145(4):455-67. PubMed ID: 19344402
[TBL] [Abstract][Full Text] [Related]
46. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.
Lai Y; Zhou L; Yi S; Chen Y; Tang Y; Yi S; Yang Z; Wei H; Zheng C; He S
Blood Cells Mol Dis; 2017 Mar; 63():52-57. PubMed ID: 28160732
[TBL] [Abstract][Full Text] [Related]
47. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.
Vathipadiekal V; Farrell JJ; Wang S; Edward HL; Shappell H; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Simkin I; Farrer LA; Jiang Z; Luo HY; Huang S; Mostoslavsky G; Murphy GJ; Patra PK; Chui DH; Alsultan A; Al-Ali AK; Sebastiani P; Steinberg MH
Am J Hematol; 2016 Nov; 91(11):1118-1122. PubMed ID: 27501013
[TBL] [Abstract][Full Text] [Related]
48. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
[TBL] [Abstract][Full Text] [Related]
49. Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model.
Suzuki M; Yamazaki H; Mukai HY; Motohashi H; Shi L; Tanabe O; Engel JD; Yamamoto M
Mol Cell Biol; 2013 Apr; 33(8):1687-95. PubMed ID: 23428869
[TBL] [Abstract][Full Text] [Related]
50. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.
Galarneau G; Palmer CD; Sankaran VG; Orkin SH; Hirschhorn JN; Lettre G
Nat Genet; 2010 Dec; 42(12):1049-51. PubMed ID: 21057501
[TBL] [Abstract][Full Text] [Related]
51. Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations.
Sebastiani P; Wang L; Nolan VG; Melista E; Ma Q; Baldwin CT; Steinberg MH
Am J Hematol; 2008 Mar; 83(3):189-95. PubMed ID: 17918249
[TBL] [Abstract][Full Text] [Related]
52. Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.
Habara AH; Shaikho EM; Steinberg MH
Am J Hematol; 2017 Nov; 92(11):1233-1242. PubMed ID: 28736939
[TBL] [Abstract][Full Text] [Related]
53. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
[TBL] [Abstract][Full Text] [Related]
54. SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon.
Pule GD; Bitoungui VJN; Chemegni BC; Kengne AP; Wonkam A
BMC Res Notes; 2017 May; 10(1):183. PubMed ID: 28499394
[TBL] [Abstract][Full Text] [Related]
55. The genetics of hemoglobin A2 regulation in sickle cell anemia.
Griffin PJ; Sebastiani P; Edward H; Baldwin CT; Gladwin MT; Gordeuk VR; Chui DH; Steinberg MH
Am J Hematol; 2014 Nov; 89(11):1019-23. PubMed ID: 25042611
[TBL] [Abstract][Full Text] [Related]
56. Experimental generation of SNP haplotype signatures in patients with sickle cell anaemia.
Menzel S; Qin J; Vasavda N; Thein SL; Ramakrishnan R
PLoS One; 2010 Sep; 5(9):e13004. PubMed ID: 20886046
[TBL] [Abstract][Full Text] [Related]
57. Localisation of cis regulatory elements at the beta-globin locus: analysis of hybrid haplotype chromosomes.
Ofori-Acquah SF; Lalloz MR; Layton DM
Biochem Biophys Res Commun; 1999 Jan; 254(1):181-7. PubMed ID: 9920754
[TBL] [Abstract][Full Text] [Related]
58. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
[TBL] [Abstract][Full Text] [Related]
59. Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β-Thalassemia Intermedia Patients.
Lai Y; Chen Y; Chen B; Zheng H; Yi S; Li G; Wei H; He S; Zheng C
Hemoglobin; 2016 Nov; 40(6):405-410. PubMed ID: 28361591
[TBL] [Abstract][Full Text] [Related]
60. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia
Heitzer AM; Longoria J; Rampersaud E; Rashkin SR; Estepp JH; Okhomina VI; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Hankins JS
Curr Res Transl Med; 2022 Jul; 70(3):103335. PubMed ID: 35303690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
